| |
|
|
|
AVITA Therapeutics Inc.  
|
|
28.69 0.09 (0%) |
09-18 16:00 |
|
Open: |
28.94 |
Pre close: |
28.6 |
Target:
|
34.27 
|
|
High: |
29.34 |
Low: |
28.69 |
Resistance:
|
29.34
34.27
|
|
Volume: |
758,824 |
Market Cap: |
616M |
Support:
|
24.02
20.73
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
28.09
|
MACD |
MACD(12,26):
|
1.14 |
|
MA(20): |
25.73 |
Signal(12,26,9): |
0.81 |
|
MA(100): |
27.41  |
Stochastic Oscillator |
%K(14,3):
|
89.20 |
|
MA(250): |
35.01 |
%D(3): |
87.22 |
|
Average Volume(K) |
3-Month: |
12572
|
52-Week |
High:
|
55.35 |
|
10-Days: |
18160 |
Low: |
20.00 |
|
RSI |
RSI(14):
|
66.51 |
Change(%): |
-26.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-90.2 |
Shares Out. (M) |
21.47 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-49.3 |
Shares Float (M) |
84.15 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
80.3 |
% Held by Institutions |
0.00 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.526 |
Shares Short (K) |
196 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-1.966 |
P/E |
0.00 |
|
Sales Per Share |
0.664 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
-294.68 |
Operating Cash Flow
(M) |
-22.75 |
P/S |
43.19 |
|
Operating Margin |
-299.23 |
Levered Free Cash Flow
(M) |
-8.60 |
P/CF |
-27.08 |
|
|
|
|
|
|
